Success Metrics

Clinical Success Rate
66.7%

Based on 4 completed trials

Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
25%(1 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_4
1
14%
Ph early_phase_1
1
14%
Ph phase_2
1
14%
Ph phase_3
2
29%

Phase Distribution

1

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
2(28.6%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(2)
Other(1)

Detailed Status

Completed4
Terminated2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
66.7%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 32 (28.6%)
Phase 41 (14.3%)
N/A2 (28.6%)

Trials by Status

terminated229%
unknown114%
completed457%

Recent Activity

0 active trials
Showing 5 of 7
completedphase_3

A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)

NCT01208181
completednot_applicable

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

NCT05256342
unknownearly_phase_1

Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib

NCT05142098
terminatedphase_2

Modulation of the Surgical Inflammatory Response by Etoricoxib

NCT00746720
completednot_applicable

Pulse Shortwave Therapy in Cervical Osteoarthritis

NCT03542955
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT01208181Phase 3

A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107)

Completed
NCT05256342Not Applicable

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

Completed
NCT05142098Early Phase 1

Comparison of the Anti-Inflammatory Efficacy of Preemptive Dexamethasone and Etoricoxib

Unknown
NCT00746720Phase 2

Modulation of the Surgical Inflammatory Response by Etoricoxib

Terminated
NCT03542955Not Applicable

Pulse Shortwave Therapy in Cervical Osteoarthritis

Completed
NCT03582332Phase 4

Serum Creatinine Change / Renal Adverse Effect With Use of Non-steroidal Painkillers in Axial Spondyloarthritis Patients

Completed
NCT00876317Phase 3

Etoricoxib in Acute Soft Tissue Rheumatism Affecting the Shoulder

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7